[The L-dihydroxyphenylalanine (L-DOPA) Effect in Parkinson's Syndrome in Man: On the Pathogenesis and Treatment of Parkinson Akinesis]

Overview

Journal Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr

Specialty Neurology

Date 1962 Jan 1

PMID 13971142

Citations 51

Authors

W Birkmayer

O Hornykiewicz

Affiliations

Soon will be listed here.

Citing Articles

Levodopa Impairs Lysosomal Function in Sensory Neurons In Vitro.

Olaoye O, Aksoy A, Hyytiainen S, Narits A, Hickey M Biology (Basel). 2024; 13(11).

PMID: 39596848 PMC: 11591693. DOI: 10.3390/biology13110893.

The New Zealand Parkinson's progression programme.

MacAskill M, Pitcher T, Melzer T, Myall D, Horne K, Shoorangiz R J R Soc N Z. 2024; 53(4):466-488.

PMID: 39439968 PMC: 11459764. DOI: 10.1080/03036758.2022.2111448.

Effect of altered production and storage of dopamine on development and behavior in .

Lee I, Knickerbocker A, Depew C, Martin E, Dicent J, Miller G Front Toxicol. 2024; 6:1374866.

PMID: 39219718 PMC: 11363549. DOI: 10.3389/ftox.2024.1374866.

Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?.

Sackner-Bernstein J J Neurol. 2024; 271(8):5687-5695.

PMID: 38904783 PMC: 11319508. DOI: 10.1007/s00415-024-12526-7.

Aberrations in temporal dynamics of cognitive processing induced by Parkinson's disease and Levodopa.

Kiani M, Heidari Beni M, Aghajan H Sci Rep. 2023; 13(1):20195.

PMID: 37980451 PMC: 10657430. DOI: 10.1038/s41598-023-47410-3.

References

BERTLER A, ROSENGREN E . Occurrence and distribution of dopamine in brain and other tissues. Experientia. 1959; 15(1):10-1. DOI: 10.1007/BF02157069. View

McGeer P, Boulding J, Gibson W, Foulkes R . Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. JAMA. 1961; 177:665-70. DOI: 10.1001/jama.1961.03040360001001. View

WESTERMANN E, Balzer H, KNELL J . [Inhibition of serotonin formation by alpha-methyl-DOPA]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958; 234(3):194-205. View

Barbeau A, Murphy G, Sourkes T . Excretion of dopamine in diseases of basal ganglia. Science. 1961; 133(3465):1706-7. DOI: 10.1126/science.133.3465.1706-a. View

Murphy G, Sourkes T . The action of antidecarboxylases on the conversion of 3,4-dihydroxyphenylalanine to dopamine in vivo. Arch Biochem Biophys. 1961; 93:338-43. DOI: 10.1016/0003-9861(61)90276-4. View

SOURKES T, HENEAGE P, TRANO Y . Enzymatic decarboxylation of isomers and derivatives of dihydroxyphenylalanine. Arch Biochem Biophys. 1952; 40(1):185-93. DOI: 10.1016/0003-9861(52)90086-6. View

Pletscher A, Shore P, Brodie B . Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther. 1956; 116(1):84-9. View

Bernheimer H, Birkmayer W, Hornykiewicz O . [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors]. Wien Klin Wochenschr. 1962; 74:558-9. View

HOLTZ P, WESTERMANN E . [Nerve tissue DOPA decarboxylase and histidine decarboxylase]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1956; 227(6):538-46. View

10.

Birkmayer W, Hornykiewicz O . [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. Wien Klin Wochenschr. 1961; 73:787-8. View

11.

Carlsson A . The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959; 11(2, Part 2):490-3. View

12.

Holzbauer M, Vogt M . Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J Neurochem. 1956; 1(1):8-11. DOI: 10.1111/j.1471-4159.1956.tb12048.x. View

13.

Ehringer H, Hornykiewicz O . [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr. 1960; 38:1236-9. DOI: 10.1007/BF01485901. View

14.

Pletscher A . [Effect of isopropyl-isonicotinic acid hydrazide on the metabolism of catechol amines and 5-hydroxytryptamine in the brain]. Schweiz Med Wochenschr. 1957; 87(50):1532-4. View

15.

Carlsson A, Lindqvist M, Magnusson T, WALDECK B . On the presence of 3-hydroxytyramine in brain. Science. 1958; 127(3296):471. DOI: 10.1126/science.127.3296.471. View

16.

Hornykiewicz O . The action of dopamine on the arterial blood pressure of the guinea-pig. Br J Pharmacol Chemother. 1958; 13(1):91-4. PMC: 1481693. DOI: 10.1111/j.1476-5381.1958.tb00197.x. View

17.

BLASCHKO H, BURN J, LANGEMANN H . The formation of noradrenaline from dihydroxyphenylserine. Br J Pharmacol Chemother. 1950; 5(3):431-7. PMC: 1509942. DOI: 10.1111/j.1476-5381.1950.tb00593.x. View

18.

Birkmayer W, Schmid S . [Effect of pyridoxin in diseases of the central nervous system]. Klin Med Osterr Z Wiss Prakt Med. 1950; 5(9):417-21. View

19.

Axelrod J . The metabolism of catecholamines in vivo and in vitro. Pharmacol Rev. 1959; 11(2, Part 2):402-8. View

20.

UDENFRIEND S, Weissbach H, BOGDANSKI D . Biochemical findings relating to the action of serotonin. Ann N Y Acad Sci. 1957; 66(3):602-8. DOI: 10.1111/j.1749-6632.1957.tb40750.x. View